Bank of Montreal’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,405
| Closed | -$269K | – | 3841 |
|
|
2021
Q1 | $269K | Sell |
3,405
-8,109
| -70% | -$641K | ﹤0.01% | 2618 |
|
|
2020
Q4 | $1.29M | Buy |
11,514
+8,191
| +246% | +$917K | ﹤0.01% | 1733 |
|
|
2020
Q3 | $138K | Sell |
3,323
-1,665
| -33% | -$69.1K | ﹤0.01% | 2541 |
|
|
2020
Q2 | $181K | Buy |
+4,988
| New | +$181K | ﹤0.01% | 2439 |
|
|
2020
Q1 | – | Sell |
-7,656
| Closed | -$150K | – | 3864 |
|
|
2019
Q4 | $150K | Buy |
7,656
+3,067
| +67% | +$60.1K | ﹤0.01% | 2809 |
|
|
2019
Q3 | $71K | Buy |
4,589
+211
| +5% | +$3.27K | ﹤0.01% | 2988 |
|
|
2019
Q2 | $89K | Buy |
4,378
+4,368
| +43,680% | +$88.8K | ﹤0.01% | 2958 |
|
|
2019
Q1 | $0 | Sell |
10
-1,544
| -99% | – | ﹤0.01% | 3968 |
|
|
2018
Q4 | $20K | Buy |
1,554
+510
| +49% | +$6.56K | ﹤0.01% | 3286 |
|
|
2018
Q3 | $17K | Buy |
1,044
+15
| +1% | +$244 | ﹤0.01% | 3437 |
|
|
2018
Q2 | $12K | Buy |
1,029
+349
| +51% | +$4.07K | ﹤0.01% | 3569 |
|
|
2018
Q1 | $7K | Sell |
680
-2,320
| -77% | -$23.9K | ﹤0.01% | 3572 |
|
|
2017
Q4 | $18K | Buy |
3,000
+2,983
| +17,547% | +$17.9K | ﹤0.01% | 3298 |
|
|
2017
Q3 | $0 | Buy |
+17
| New | – | ﹤0.01% | 3869 |
|
|
2017
Q1 | – | Sell |
-13
| Closed | – | – | 3710 |
|
|
2016
Q4 | $0 | Sell |
13
-1
| -7% | – | ﹤0.01% | 3743 |
|
|
2016
Q3 | $0 | Sell |
14
-271
| -95% | – | ﹤0.01% | 3773 |
|
|
2016
Q2 | $0 | Buy |
285
+278
| +3,971% | – | ﹤0.01% | 3829 |
|
|
2016
Q1 | $0 | Sell |
7
-5
| -42% | – | ﹤0.01% | 3943 |
|
|
2015
Q4 | $0 | Sell |
12
-19
| -61% | – | ﹤0.01% | 4009 |
|
|
2015
Q3 | $0 | Buy |
31
+8
| +35% | – | ﹤0.01% | 3753 |
|
|
2015
Q2 | $0 | Sell |
23
-1,977
| -99% | – | ﹤0.01% | 3714 |
|
|
2015
Q1 | $10K | Buy |
+2,000
| New | +$10K | ﹤0.01% | 3263 |
|